Literature DB >> 24510883

In vitro models of the blood-brain barrier.

Cathrin J Czupalla1, Stefan Liebner, Kavi Devraj.   

Abstract

The blood-brain barrier (BBB) proper is composed of endothelial cells (ECs) of the cerebral microvasculature, which are interconnected by tight junctions (TJs) that in turn form a physical barrier restricting paracellular flux. Tight control of vascular permeability is essential for the homeostasis and functionality of the central nervous system (CNS). In vitro BBB models have been in use for decades and have been of great benefit in the process of investigating and understanding the cellular and molecular mechanisms underlying BBB establishment. BBB integrity changes can be addressed in vitro by determining cell monolayer permeability (Pe) to different solutes and measuring trans-endothelial electrical resistance (TEER).This chapter describes procedures that can be utilized for both freshly isolated mouse brain microvascular ECs (MBMECs) and murine or human brain EC lines (bEnd5 or hCMEC/D3), cultivated either as a single monolayer or in cocultivation with primary mouse astrocytes (ACs). It starts with detailed information on how to perform transwell cell culture, including coating of inserts and seeding of the ECs and ACs. Moreover, it encompasses instructions for electrical assessment of the in vitro BBB using the more recent cellZscope(®) device, which was traditionally performed with chopstick electrodes of voltohmmeter type (EVOM). From continuous impedance measurements, the cellZscope(®) device provides TEER (paracellular resistance) and cell membrane capacitance (Ccl-transcellular resistance), two independent measures of monolayer integrity. Additionally, this chapter provides guidance through subsequent experiments such as permeability analysis (Pe, flux), expression analysis (qRT-PCR and Western blotting), and localization analysis of BBB junction proteins (immunocytochemistry) using the same inserts subjected earlier to impedance analysis.As numerous diseases are associated with BBB breakdown, researchers aim to continuously improve and refine in vitro BBB models to mimic in vivo conditions as closely as possible. This chapter summarizes protocols with the intention to provide a collection of BBB in vitro assays that generate reproducible results not only with primary brain ECs but also with EC lines to open up the field for a broader spectrum of researchers who intend to investigate the BBB in vitro particularly aiming at therapeutic aspects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24510883     DOI: 10.1007/978-1-4939-0320-7_34

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  48 in total

Review 1.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

Review 2.  Controversial roles for dexamethasone in glioblastoma - Opportunities for novel vascular targeting therapies.

Authors:  Daniel Dubinski; Elke Hattingen; Christian Senft; Volker Seifert; Kevin G Peters; Yvonne Reiss; Kavi Devraj; Karl H Plate
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-25       Impact factor: 6.200

3.  Adapting coculture in vitro models of the blood-brain barrier for use in cancer research: maintaining an appropriate endothelial monolayer for the assessment of transendothelial migration.

Authors:  Elodie Vandenhaute; Aurore Drolez; Emmanuel Sevin; Fabien Gosselet; Caroline Mysiorek; Marie-Pierre Dehouck
Journal:  Lab Invest       Date:  2016-02-22       Impact factor: 5.662

Review 4.  Connexin Channels at the Glio-Vascular Interface: Gatekeepers of the Brain.

Authors:  Marijke De Bock; Luc Leybaert; Christian Giaume
Journal:  Neurochem Res       Date:  2017-06-20       Impact factor: 3.996

5.  In vitro models of molecular and nano-particle transport across the blood-brain barrier.

Authors:  Cynthia Hajal; Marco Campisi; Clara Mattu; Valeria Chiono; Roger D Kamm
Journal:  Biomicrofluidics       Date:  2018-05-31       Impact factor: 2.800

Review 6.  In-vitro blood-brain barrier modeling: A review of modern and fast-advancing technologies.

Authors:  Farzane Sivandzade; Luca Cucullo
Journal:  J Cereb Blood Flow Metab       Date:  2018-07-30       Impact factor: 6.200

Review 7.  Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking.

Authors:  Pawan Kumar Pandey; Ashok Kumar Sharma; Umesh Gupta
Journal:  Tissue Barriers       Date:  2015-12-15

8.  The blood-brain barrier studied in vitro across species.

Authors:  Maj Schneider Thomsen; Nanna Humle; Eva Hede; Torben Moos; Annette Burkhart; Louiza Bohn Thomsen
Journal:  PLoS One       Date:  2021-03-12       Impact factor: 3.240

9.  Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy.

Authors:  Jiong Hu; Sarah Dziumbla; Jihong Lin; Sofia-Iris Bibli; Sven Zukunft; Julian de Mos; Khader Awwad; Timo Frömel; Andreas Jungmann; Kavi Devraj; Zhixing Cheng; Liya Wang; Sascha Fauser; Charles G Eberhart; Akrit Sodhi; Bruce D Hammock; Stefan Liebner; Oliver J Müller; Clemens Glaubitz; Hans-Peter Hammes; Rüdiger Popp; Ingrid Fleming
Journal:  Nature       Date:  2017-12-06       Impact factor: 49.962

10.  Nucleoside diphosphate kinase B regulates angiogenic responses in the endothelium via caveolae formation and c-Src-mediated caveolin-1 phosphorylation.

Authors:  Shalini Gross; Kavi Devraj; Yuxi Feng; Jadranka Macas; Stefan Liebner; Thomas Wieland
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.